Crossmark

Repurposing of clinically proven bioactive compounds for targeted treatment of Alzheimer’s disease using molecular docking approach

Published Online: 2023-10-31

Authors

Vasanth Kanth, Thasma Loganath Babu

Raha, Archi

Vijay Murali, R M

Yuvatha, Natesan

Kumaran, Kasinathan

Kirubakaran, Rangasamy

ArulJothi, KN
License Information

Text and Data Mining valid from 2023-10-31

Version of Record valid from 2023-10-31
More Information

Article History

Received: 3 February 2023

Accepted: 12 October 2023

First Online: 31 October 2023

Declarations

:

: Not applicable.

: Not applicable since the project only involves an <i>in-silico</i> Molecular docking study of the compounds listed.

: The authors declare no competing interests.

Document is current